Williford, Kellie M. http://orcid.org/0000-0002-7405-6459
Taylor, Anne
Melchior, James R.
Yoon, Hye Jean http://orcid.org/0000-0002-3830-3678
Sale, Eryn
Negasi, Milen D.
Adank, Danielle N. http://orcid.org/0000-0002-8206-6702
Brown, Jordan A.
Bedenbaugh, Michelle N.
Luchsinger, Joseph R.
Centanni, Samuel W. http://orcid.org/0000-0002-3941-7677
Patel, Sachin http://orcid.org/0000-0001-8052-520X
Calipari, Erin S. http://orcid.org/0000-0003-4723-0623
Simerly, Richard B.
Winder, Danny G. http://orcid.org/0000-0002-6185-4769
Funding for this research was provided by:
Howard Hughes Medical Institute (GT11385)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1F99NS120599-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01-DA042475-06A1)
Article History
Received: 2 December 2022
Revised: 13 February 2023
Accepted: 5 March 2023
First Online: 20 March 2023
Competing interests
: The authors declare no competing interests.